We found that CAR-M locally administered in HER2+ tumors simultaneously controlled growth of contralateral HER2-negative tumors and prevented antigen-negative relapse upon HER2-negative tumor rechallenge, indicating epitope spreading and induction of long-term immune memory. Here, ERBB2 is linked to neoplasm.